FDA Issues a Drug Shortage for Hydroxyzine Pamoate
Resilinc-blog

According to the U.S. Food and Drug Administration (FDA), Sandoz and Teva Pharmaceuticals announced a drug shortage for their hydroxyzine pamoate oral capsules on Tuesday, March 12.

Read All Global Disruptions

Recent Global Disruptions